Please ensure Javascript is enabled for purposes of website accessibility

Gilead Sciences(GILD)

Nasdaq Global Select

GILD
Gilead Sciences Stock Quote
$71.19 -$0.50 -0.7%
Price as of September 24, 2021, 4:00 p.m. ET View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

Interactive Chart


Compare GILD Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
GILD
Gilead Sciences
$71.19 $89B 19.4% 5.3%
ILMN
$432.82 $63B 51.2% 142.5%
EXEL
$20.35 $6B -12.4% 32.9%
BMY
$60.23 $134B 6.6% 25.8%
VRTX
$183.61 $48B -30.2% 108.0%

News & Analysis: Gilead Sciences

The Fool has written over 1800 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings